In fact biallelic inactivation of SETD2 gene has been previously demonstrated in other cancer types by both double mutations occurring on separate alleles of SETD2 in individual patients with acute leukaemias33 or by concurrent 3p loss and loss-of-function SETD2 mutation in the remaining allele in renal cell carcinomas22. The gene discussed is SETD2; the disease is cancer.